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Summary: Although bilirubin interferes with the enzymatic assays for creatinine, neither a consensus of the
degree of interference nor the mechanism has been established. Using multiple regression analysis, we
demonstrate that the interference is negative and caused by both analyte-dependent and analyte-independent
mechanisms. Furthermore, the correlative model includes terms non-linear with respect to creatinine. In the
kinetic creatinine phenol-aminophenazone peroxidase method, there are analyte-dependent and analyte-
independent mechanisms at work. The multivariate equation is: Crea' = 0.9879 Crea — 0.4524 Bili —
0.000828 Crea χ Bili + 2.094 χ 10~7 Crea2 χ Bili + 5.0 (Crea' = measured creatinine (μτηοΐ/ΐ), Crea =
true creatinine (μιηοΐ/ΐ), and Bili = conjugated bilirubin (μιηοΐ/ΐ)). The endpoint mode was affected less than
the kinetic mode and exhibited different relationships in which two models describe the interference equally
well. One is strictly analyte-dependent: Crea' = 0.9991 Crea - 0.00203 Crea χ Bili + 2.390 χ 10~6 Crea2
χ Bili - 1.464 χ 10~9 Crea3 χ Bili + 3.261 χ 10~13 Crea4 χ Bili - 9.9. The other is a complex combined
analyte-dependent and analyte-independent: Crea' = 0.9834 Crea - 0.00680 Crea χ Bili + 2.477 χ 10~7
Crea2 χ Bili - 3.233 χ ΙΟ"7 Crea χ Bili2 + 0.4652 Bili - 0.000458 Bili2 + 12.2. These models are valid
for creatinine concentrations up to 2200 μπιοΐ/ΐ (24.9 mg/dl) and bilirubin up to 660 μπιοΐ/l (38.6 mg/dl). The
interference increases with increments of either bilirubin or creatinine. In addition, we found that unconjugated
bilirubin interferes differently from conjugated bilirubin in degree and mechanism. Model building, contour
plots, surface plots, and possible mechanisms are discussed. We propose multiple regression analysis as the
proper way to evaluate interferences because analyte-dependence can be easily missed by simple regression
analysis. True creatinine concentrations can be estimated despite the interference from conjugated bilirubin.
Other phenol-aminophenazone peroxidase methods may be similarly affected.
Introduction - , * r * j - - * jOur approach to interference studies is to derive a
Bilirubin is a well known negative interferent of the correlative equation by multiple regression analysis
Jaffa method. There is some concern as to the degree (7). The equation will contain terms which can be
of susceptibility for the phenol-aminophenazone per- called analyte-dependent or analyte-independent. An-
oxidase (PAP) method since compared with the Jaffe alyte-independence is a term in which the degree of
method in some studies (1, 2), the enzymatic assays interference depends upon only the concentration of
for creatinine demonstrated less susceptibility to bil- the interferent (8, 9). An example of this is pseudo-
irubin and more as reported in others (3, 4). More- hyponatraemia is proportional only to the volume
over, published works suggest that conjugated bili- displacement caused by lipids. Another example is
rubin interferes more than unconjugated bilirubin in alkaline phosphatase, which when measured on the
enzymatic assays (5, 6). SMAC, is interfered by methotrexate because it ab-
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sorbs light at 340 nm like the product (10). Analyte-
dependence, on the other hand, indicates that the
interference depends upon the concentrations of both
the inlerferent and the analyte. The dependence on
the analyte does not necessarily mean that there is a
reaction between the interferent and the analyte. More
likely, there is a reaction, but not necessarily a chem-
ical one, between the interferent and a product created
by the reaction of the analyte and the reagents. The
very nature of analyte-dependence implies non-li-
nearity in an equation because of the cross-product
term between the two. This concept is important
because human intuition is poor in predicting re-
sponses in non-linear systems. The approach we have
used will always detect the possibility of such inter-
actions which simple regression fails to do. In addi-
tion, multivariate approach can handle systems where
multiple interferents are not only present but which
can interact among themselves as well as with the
analyte or its products. This subject and its theoretical
foundations have been discussed by Kroll & Chester
(7).
In an earlier study, we developed a correlative model
for the effect of unconjugated bilirubin on this assay.
The effect was a complex analyte-dependent relation-
ship without any evidence of analyte-independent
mechanisms (11). Our aim is to explore the relation-
ship of creatinine and conjugated bilirubin in the
enzymatic creatinine assay. To our knowledge, neither
a thorough quantitative analysis of the conjugated
bilirubin interference in the enzymatic assay nor an
analysis of the analyte-dependence of the interference
has been done. In part this is because of the difficulty
in obtaining conjugated bilirubin and its instability.
Hence a synthetic conjugated bilirubin was used in
this study. The literature supports the use of synthetic
conjugated bilirubin as a substitute for the natural
product (5, 6, 12 — 14). Using multivariate regression
(7 — 9), we demonstrated analyte-dependent and an-
alyte-independent interferences. The derived equa-
tions are more complicated than the model to describe
the interference from unconjugated bilirubin. Also
discussed in this paper are the advantages of using
multiple regression over standard regression, contour
plots, surface plots, model building, and the possible
mechanisms of interference will be addressed. Because
this approach is still new, particular emphasis is placed
on the model building and statistical aspects of this
approach. Implications for other phenol-aminophen-
azone peroxidase based assays, such as for cholesterol,
are mentioned. We believe the multivariate analysis
approach is the proper method to examine interfer-
ences. There is no reason to assume that chemical
interactions are linear over the broad range that exists
in biochemical measurements of patients. In this re-
search, we studied the enzymatic phenol-aminophen-
azone peroxidase method in the kinetic and endpoint
modes. Our purpose is to seek further information on




Creatinine was obtained from MIST (lot 914, Gaithersburg,
MD). Synthetic ditaurine bilirubin derivative was obtained
from Lee Scientific Inc. (lot C 64500, cat 910-10, St. Louis,
MO). A kit to analyze creatinine by the enzymatic phenol
derivative-aminophenazone-peroxidase method was gotten
from Boehringer Mannheim (cat 883263, Indianapolis, IN).
When prepared according to the manufactuter's instructions,
this kit contains solutions of the following concentrations:
Working Solution #1: 4.3 mmol/1 4-aminophenazone,
> 20000 U/i creatinase (EC 3.5.3.3; Pseudomonas species;
25 °C), > 12000 U/l sarcosine oxidase (EC 1.5.3.1; Pseudo-
monas species; 25 °C), 1000 U/l peroxidase (EC 3.1.1.13; horse-
radish; 25 °C), > 10000 U/l ascorbate oxidase (EC 1.10.3.3;
Cucurbita species; 25 °C), 100 μτηοΙ/1 potassium phosphate buf-
fer (pH 7.9), 8.6 μιηοΐ/ΐ 2,4,6-tribromo-3-hydroxybenzoic acid,
5 μηιοΐ/ΐ potassium hexacyanoferrate(II), 3 g/1 detergent and
Working Solution #2: (start reagent) > 164000 U/l creatini-
nase (EC 3.5.2.10; Alcaligenes species; 25 °C), 20 μηιοΐ/l potas-
sium phosphate buffer (pH 7.9), 3 g/1 detergent.
Methods
Creatininase converts creatinine to creatine; creatinase converts
creatine to sarcosine and urea. Sarcosine oxidase converts sar-
cosine, water, and oxygen to glycine, formaldehyde, and hy-
drogen peroxide, The hydrogen peroxide reacts with modified
Trinder reagents to produce a red chromophore whose absorb-









Sarcosine + H2O Sarcosine oxidase
4- O2 * 4- HCHO 4- H2O2
H2O2 + Phenol D , ,derivative + Peroxidase t Red benzoquinone-
4-Aminophenazone imine d^e
Ins t rumenta t ion
The Boehringer Mannheim Creatinine phenol-aminophenazone
peroxidase kit can be adapted to several automated instruments
as well as performed as a manual method. The Creatinine
phenol-aminophenazone peroxidase method can be run in the
endpoint or kinetic mode, both of which we used. Conditions
were optimized for use on a Cobas Mira (Roche Diagnostic
Systems, Nutley, NJ, USA) using aqueous standards. The set-
tings we employed are in listed in table 1.
Solutions
Creatinine
By dissolving 50 mg creatinine in» 10 ml of pooled serum, we
made a 422 mmol/1 stock solution.
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Sample diluent (μΐ water)
Reagent 1 volume (μΐ)





Reagent 2 volume (μΐ)
Reagent 2 diluent (μΐ)









































In a dimly lit room, we dissolved 20 mg of ditaurine bilirubin
in 25ml of pooled serum, to produce a 13.68 mmol/1 stock
solution. We added varying volumes of the stock solution to a
human serum pool that we had filtered three times using What-
man #1 filter paper, followed by a 0.45 μπα, and then a 0.2
μπι membrane to produce six different concentrations of bili-
rubin. Using the method of Jendrassik & Grof (15), we meas-
ured the bilirubin for both methods at 6.8, 80.4, 160.7, 326.6,
458.3, and 656.6 μηιοΐ/ΐ on the Hitachi 736 (Boehringer Mann-
heim, Indianapolis, IN).
Construct ion of a sample mat r ix
We created a matrix of samples in which the creatinine and
bilirubin varied independently of one another (7, 9). The bili-
rubin concentration increased across the rows and the creatinine
concentration increased down the columns. We divided each
bilirubin pool into six aliquots and to each we added equal
volumes of the pooled serum with added creatinine to produce
six different concentrations, hence thirty-six specimens in all.
The concentrations of creatinine, before the interferent was
added, measured 221, 345, 583, 1043, 1618, and 2086 μπιοΐ/ΐ
for the endpoint mode and 221, 345, 592, 1061, 1653, and 2175
μπιοΙ/1 for the kinetic mode.
Results
We set up the enzymatic phenol-aminophenazone per-
oxidase method according to standard methods op-
timizing the sample to reagent ratios and the meas-
uring times of the assay for the Cobas Mira (tab. 1).
The correlation between the measured creatinine and
the creatinine standards were y = 0.986x + 0.09 and
y = 1.02x + 0.02 (y = measured creatinine; χ =
aqueous standard mg/dl) for the kinetic and endpoint
Tab. 2. Effects of conjugated bilirubin and creatinine on the
creatinine phenol-aminophenazone peroxidase method
Bilirubin (μπιοΐ/ΐ)*
6.8 80.4 160.7 326.6 458.3 656.6












































































* The bilirubin concentration for each result is given in the
top row.
** Absorbance too low for instrument to calculate a value
















































































































SE8|0pc = standard error of the slope
MSr =
P
mean square of the residuals
probability of the null hypothesis being true, i. e. the slope is not significantly different from zero
Bur. J. Clin. Chem. Clin. Biochem. / Vol. 31,1993 / No. 12
842 Eng et al.: Analyte-dependenl/-independent interferences by bilirubin on creatinine PAP
calculations, respectively. These methods are linear to
at least 2210 μιηοΐ/ΐ (25 mg/dl). The kinetic assay had
within-run coefficient of variations (n = 6) of 3.2%
and 1.4% for the low (Precical) and high control
(Precitrol), respectively. The coefficients of variation
for the endpoint assay were 3.2% and 0,7% for the
low and high control, respectively. The results for
precision are similar to that reported in the literature
(16, 17).
As can be seen from table 2, we tested a matrix in
which both the concentrations of creatinine and con-
jugated bilirubin varied over a broad range. There are
marked decreases in the measured creatinine as the
concentration of conjugated bilirubin increased. The
percentage drop is greater at lower concentrations of
creatinine. The influence of the two components were
analyzed by multivariate regression on a Macintosh
SE using the program Stat View SE+ Graphics (Ab-
acus Concepts Inc., 1988) and following the rules for
analyzing analyte-dependent interferences. These
methods are described by Kroll & Chester (7) and by
Draper & Smith (18).
The typical response of the assay to bilirubin for both
the kinetic and endpoint methods appears to be a
linear relationship with a negative slope (coefficient).
A simple linear regression of the data in table 2
produces a different negative slope for each set of
creatinine concentrations (tab. 3). Some of these
slopes vary significantly from one another. Figure 1
shows plots of the slopes from table 3 plotted against
the various starting creatinine concentrations. The








+ 4.043 χ 10~6 Crea2
- 2.451 χ ΙΟ'9 Crea3
+ 5.299 χ ΙΟ'13 Crea4
(r2 = 1.000)
*= - 0.3694 - 0.00103 Crea





= 0.1276 - 0.00100 Crea
+ 2.952 χ 10~7 Crea2
(r2 = 0.978)
also fits the endpoint method. If the interferences were
straightforward, that is, simple analyte-independence,





Fig. 1. Plot of slopes, ^, , derived from simple regression analysis (tab. 3) vs. creatinine
ο Endpoint Mode:
dCrea/dBili = 0.222 - 0.0031 Crea + 4.04 χ ΙΟ"6 Crea2 - 2.45 χ ΙΟ"' Crea3 + 5.30 χ 10~'3 Crea4
ο Kinetic Mode: -
dCrea/dBili = -0.369 - 0.0010 Crea + 2.91 χ ΙΟ"7 Crea2
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A stepwise procedure was used to generate the mul-
tivariate models:
Crea' = b00 + bi0 Crea H- b0i Bili
+ b20 Crea2 + bn Crea Bili + b02 Bili2
+ b30 Crea3 + b2, Crea2 Bili
+ bI2 Crea Bili2 + b03 Bili3
+ b^ Crea4 + b31 Crea3 Bili
+ b22 Crea2 Bili2 + b13 Crea Bili3
+ b04 Bili4,





















a) 2 parameter 33
Crea
Crea χ Bili
b) 2 parameter 33
Crea
Bili

















f) 2 parameter 31
Crea
Crea χ Bili
g) 2 parameter 31
Crea
Bili










j) 4 parameter 28
Crea
Crea χ Bili












* Five parameter analyte-dependent model (e)
** Four parameter analyte-dependent plus analyte-independ-
ent model (j)
where Crea' is the creatinine measured by the phenol-
aminophenazone peroxidase assay. Then we manually
tested the models using StatView with forward and
backward addition of terms. An automated stepwise
regression neither minimizes the least squares fit nor
is it a reasoned process. Moreover, programs for
desktop computers usually do not generate higher
ordered combination of variables or go back to look
at terms which are insignificant early in the analysis.
These reasons are critical to proper analysis. The
routine interference and the best fitting models are
tabulated in table 4. The models are ordered in de-
scending order according to the size of the mean
square of the residuals. To find the best fitting model
with significant coefficients (p < 0.05), we applied the
F-test (the last column in tab. 4). We compared the
model under consideration to what we considered the
best model. The 90% confidence level is 1.6.
Discussion
The basic mechanisms of interference are as follows:
(1) the interferent can either react with the reagents
only or react with the sensor, like the product;
(2) it can react with the analyte or
(3) it can react with a product of the analyte and the
reagents, interfering with the final interaction of the
product and the sensor. The sensor is the detecting
device, i.e. electrode or diode array. Only the first
case is independent of the analyte concentration, the
other two are dependent on it (8).
The standard linear regression models, that is simple
regression, are shown in table 3. They appear ade-
quate by conventional interpretation of interference,
which assumes that the interference is independent of
the analyte concentration. All the coefficients of de-
termination, r2, are above 0.89, which means that there
is less than 5.6% probability that the association is
due to chance. The slopes are significantly different
from zero because the values for ρ are less than or
equal to 0.0085 (p = 0.05 is the cut off for signifi-
cance). Therefore, each regression, in and of itself,
would be considered acceptable by current standards.
All previous studies of bilirubin interferences with the
phenol-aminophenazone peroxidase creatinine
method have assumed analyte-independence.
Examination of the slope in table 3 should be discon-
certing. In true analyte-independent interference, the
slopes of the regression should be the same over a
wide range of analyte concentrations. This however,
is not the case; these slopes vary significantly (e.g.
. Eur. J. din. Chem. Gun, Biochem. / Vol. 31,1993 / No. 12
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comparing the first two slopes of the endpoint
method, / = 3.09, υ = 8 (υ = number of degrees of
freedom); therefore, significant at the 0.02 level of
confidence). One way of verifying their significance is
to regress these slopes against the creatinine concen-
tration. Because the slopes are significantly different
from zero, the interference has an analyte-dependent
component. Figure 1 graphically reflects this analyte-
dependence (slopes from table 3) and in addition
shows the relationship to be non-linear with respect
to creatinine concentration. Therefore, standard re-
gression is insufficient to analyze the data because the
analyte-dependence is missed. Multiple regression is
the proper tool (7 — 9).
Multiple regression analyses (tab. 4) provide greater
insight than the standard regression. Complex models
that involve multiple dependent variables and non-
linear terms are easily analyzed. Moreover, multiple
regression uses the complete data set (n = 36), hence
maximizing the degrees of freedom, whereas the stan-
dard regression reduces the data set to smaller sets
thus reducing the degrees of freedom (n = 6). Table
4 lists the competing models according to the mean
square of the residuals (MSr) in descending order. The
best fitting models for the endpoint mode were the
five parameter analyte-dependent interference (model
e) and the six parameter mixed analyte-dependent and
analyte-independent interference (model d). The F-
test revealed no statistical differences between these
two models.
Two competing models also described the phenomena
affecting the kinetic mode — one having strictly an-
alyte-dependent terms (model i), and one having a
mixture of analyte-dependent and analyte-independ-
ent terms (model j). These higher order complex mod-
els are more complicated than those we found with
unconjugated bilirubin (11). These models listed
above clearly fit the data better than do the conven-
tional analyte-independent models for the equilibrium
and kinetic methods (tab. 4, b and g). In addition,
the higher-order complex models (d, e, i, and j), fit
the data better than do the first-order analyte-de-
pendent or mixed models (a, c, f, and h) by looking
at the F ratio.
Although we cannot show that a statistical difference
exists in the fit between these best competing models
(d vs. e and i vs. j) for the endpoint and kinetic modes,
respectively, they suggest different possible mechan-
isms. The mixture of analyte-dependent and analyte-
independent terms suggests that at least two different
mechanisms are at work. The complexity of these
equations may indicate more than one site of inter-
ference of the same type of reaction.











































































* Calculated only when the polynomial coefficients are signif-
icant
An alternative viewpoint of the data can help refine
the selection of models. Figure 1 shows fitted lines
through the slopes from simple regression analysis.
The partial differential of the multiple regression
equation should give the same coefficients as that of
the polynomials used to fit the plot of the slopes. The
curve that best fits the data can be found in the same
manner as the best multiple regression equation. As
shown in table 5, for the endpoint analysis, the quartic
curve (c) has borderline significant coefficients and
the F-test shows that it is the best fit. Therefore the
quartic polynomial supports the five parameter ana-
lyte-dependent endpoint (model e) in table 4 because
the partial differential of the multiple regression equa-
tion gave the same coefficients as that of the poly-
nomials used to fit the plot of the slopes (p > 0.05).
However, we cannot make a case for or against (model
d) because the bilirubin terms will not drop out in the
first order derivative, hence not simplifying the equa-
tion to one variable. The best kinetic model is a
quadratic equation (tab. 5-d) because all other models
have insignificant coefficients. This polynomial curve
fit analysis did not support the five parameter analyte-
dependent kinetic model (tab. 4-i), and hence it can
be eliminated. Therefore, we singled out the kinetic
four parameter mixed analyte-dependent and analyte-
independent model (tab. 4-j) as the model of choice.
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Tab. 6. Best fitting multiple regression models
Variable/Model Coefficient
Kinetic method (N = 33)
Four parameter mixed analyte-dependent, analyte-independent (tab. 5, model j)
Creatinine 0.9879 0.0134
Creatinine χ Bilirubin -0.00083 0.0001
Creatinine2 χ Bilirubin 2.09 χ 10~7 5.38 χ 10~8
Bilirubin -0.4524 0.0918
t-value
Endpoinl method (N = 36)


























Intercept 9.9, r 0.999










































Intercept 5.0, r2 0.997
What is important, is that the differences between the
coefficients determined by the multivariate approach
using the entire data set (tab. 4) and the polynomial
fit to the slopes (tab. 5) are not significantly greater
than zero (p > 0.05) for the analyte-dependent end-
point and the mixed analyte-dependent and -indepen-
dent kinetic methods which mathematically validates
our interpretation of the results. Table 6 list the mod-
els of choice derived from these analyses.
We have several cautionary notes about choosing and
using a model. Creating more terms in the multiple
regression equation does not necessarily mean a better
fit or if a better fit that it is a better model. As can
be seen by the MSr and SS values in table 4, these
values fall with increasing number of terms. What has
been omitted are the models with higher order terms
that have insignificant coefficients. One has to be wary
of "better fitting" higher order models as they may
be fitting the noise in the data. Another point is that,
one must always check the model against the experi-
mental data and plot the residuals ((model calculation
— data) vs. data). Performing this routine, we were
puzzled that endpoint model (i) appeared to fit poorly.
We found that a 20% round-off in the coefficient for
Crea2 χ Bili, that was originally displayed as
0.000002 instead of 0.0000023901, produced a nega-
tive bias as great as 1000 μιηοΐ/ΐ! This is because of
the power of a higher order term times a very small
coefficient can make a sizable contribution. Philo-
sophically, the simplest model that fits the data is the
most appropriate works very well in the kinetic model
but there are subtleties which can be missed. In the
endpoint method, we cannot discriminate between
models (d) and (e), both fit the data equally well.
However, mechanistically they suggest radically dif-
ferent pathways.
Comparing the four parameter mixed interference
kinetic model with the equivalent endpoint model
produced interesting results. There are no significant
differences among the coefficients of the analyte-de-
pendent terms (p > 0.05 for both creatinine χ bili-
rubin and creatinine2 χ bilirubin). This suggests that
the analyte-dependent mechanisms do not change
with time and that the any intermediates formed by
the bilirubin-creatinine interferences are permanent.
On the other hand, there is a significant difference in
the analyte-independent term (p < 0.05 for bilirubin)
that suggests transient analyte-independent mecha-
nisms. Hence, the kinetic method is affected to a
greater degree by analyte-independent effects than the
endpoint.
Similar to unconjugated bilirubin, the synthetic con-
jugated bilirubin interferes by analyte-dependent
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Creatinine [μπιοΙ/Ι]
Fig. 2. Predicted simple regression slopes, , for the experiments in which bilirubin and creatinine are varied.
Kinetic Mode: — — Conjugated bilirubin
Endpqint Mode: Conjugated biiirubin
Unconjugated bilirubin
Unconjugated bilirubin
mechanisms as manifested by cross product terms in
the multiple regression equations. Unlike Unconju-
gated bilirubin, the synthetic conjugated bilirubin is
also affected by significant analyte-independent mech-
anisms as manifested by a free bilirubin term in the
multiple regression equations. Therefore, the two bil-
irubins react somewhat differently in the coupled phe-
nol-aminophenazone peroxidase reactions. This begs
the question — which bilirubin causes a larger inter-
ference? We compared the data from this experiment
with that of Unconjugated bilirubin (11). The data
were not directly comparable as the values for bili-
rubin and starting creatinine differed. The residuals
from comparing the models of predicted creatinine
proved confusing to interpret in absence of a refer-
dCrea
dBili
ence. Comparing the polynomials used to fit
for Unconjugated bilirubin at various levels of starting
creatinine (without interferent) versus that of conju-
gated bilirubin proved enlightening. Figure 2 com-
dCreapares the predicted
dBili of conjugated bilirubin
from the polynomial used to fit the slopes from simple
regression analyses (tab. 2) with that used to describe
the Unconjugated bilirubin interference (11). The pre-
dicted simple regression slope for the kinetic mode is
more negative for conjugated bilirubin than for un-
conjugated bilirubin below creatinine concentrations
of approximately 1300 μιηοΐ/ΐ, especially at normal
creatinine concentrations where the difference can be
as high as 320% (-0.4496 vs -0.1397 μιηοΐ creati-
nine/μπιοΐ bilirubin). Hence the interference caused
by conjugated bilirubin is greater than that by un-
conjugated bilirubin. This also has been reported-by
Franzini et al. (5) and Ihara et al. (6). However, lacking
in their studies is what happens at the upper clinical
ranges of creatinine. Figure 2 shows that in the kinetic
mode the interference caused by both bilirubins not
only increase but they converge to a slope of —1.26!
We believe the same criticism can be said of work
stating a lack of interference by delta bilirubin (15).
As we have pointed out before, the whole range of
possible laboratory values must be examined in inter-
ference studies (7-9, 11). The endpoint method be-
haves differently. Unconjugated and conjugated bili-
rubin presents similar interferences (fig. 2), until the
concentration of creatinine is greater than 1300
μιηοΐ/l. Above this, the interference decreases more
rapidly for the Unconjugated bilirubin. Comparing
the kinetic mode to the endpoint mode, the kinetic
mode is more severely interfered with by either bili-
rubin. Further discussion as to why will occur when
mechanisms are discussed.
Contour plots graphically illustrate how the measured
creatinine is expected to vary over a range of true
creatinine and conjugated bilkubin values (measured
creatinine = f(true creatinine, bilirubin)). In figure 3,
the contour lines are the true creatinine concentra-
tions, The x-axis is the observed creatinme. The values
of the contours can be read off' at zero bilirubm
concentration. For example in figure 3 (bottom), the
contour line labeled 83 is 83 μτηοΐ/ΐ creatinine when
there is no interference (i. e. no conjugated bilirubin).
At 200 μιηοΐ/l conjugated bilijrjiibin, the true creatinine
of this contour would be approximately 180 μπιοΙ/1
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Kinetic, combined model
0 500 1000 1500 2000 2500
True creatinine [μπηοΙ/Ι]
Fig. 3. Contour plots;
(top) represents the kinetic mode,
(bottom) represents the endpoint mode.
but would measure 83 μιηοΐ/ΐ. No interference would
produce a family of vertical lines (z = xn). A simple
negative analyte-dependent interference (z = mxy)
would lead to a family of lines with a positive slope
(positive interference: z = —mxy). Our contour plots
fall into neither category. The phenomenon is more
complex and shows asymmetrical curves that dem-
onstrate a non-linear analyte-dependent interference.
The kinetic method, figure 3 (top), at creatinine con-
centrations below 1000 μιηοΐ/ΐ, the curves exhibit a
bow progressively to the left as the creatinine ap-
proaches normal values, thus showing a system ex-
tremely sensitive to negative interference at high bil-
irubin concentrations. The contours show that a single
slope, such as that produce by simple regression an-
aylsis, would inadequately describe the interference
over even a small range of creatinine concentrations.
As the concentrations of creatinine increase, the
curves straighten out to the point where a linear
approximation looks good over the entire range of
bilirubin. This result reflects the effects of the higher
order terms of the multiple regression equation. The
change in slope to a shallower angle reflects an in-
creasing negative interference. Figure 3 (bottom), the
endpoint method combined analyte-dependent and
Endpofnt combined model
Fig. 4. Surface response plots;
(top) represents the kinetic mode,
(bottom) represents the endpoint mode.
analyte-independent model (model (h)) has noticably
steeper slopes than figure 3 (top), which denotes less
interference. The curve on the extreme left is interest-
ing. At high concentrations it is a vertical line, indi-
cating no increasing interference with increasing bili-
rubin (i. e. tab. 2, second line of data). This may mean
a saturation of the interfering mechanism. The con-
tour plots provide a graphical explanation for the
initially discrepant information seen in table 3 and
figure 1 where the simple linear regression models
indicate a change in slopes from lower creatinine
concentrations to higher ones.
Response surface curves or surface plots are another
useful manner to see the effect of interferences. Figure
4 shows the three dimensional surface plots for the
modeled responses in the kinetic and endpoint reac-
tions. The kinetic method (4 (top)) shows that at
normal concentrations of creatinine, bilirubin pro-
duces a near linear negative response. This suggests
that the analyte-independence is the predominate
mechanism of action in this range. However, as the
domain is extended, the surface curves along the cre-
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atinine axis which denotes the analyte-dependent
mechanisms coming into play. The endpoint method
(4 (bottom)) shows a curve when bilirubin increases
when the creatinine is at normal levels. Hence, ana-
lyte-dependent mechanisms are either predominating
or significantly contributing to the interference. Sup-
port for this, can be seen in table 3, the first slope
for the endpoint method only has an r of 0.893
compared to 0.970 or better for the other levels of
creatinine. The greater curvature of the curve along
the creatinine axis compared to the kinetic method
show that the analyte-dependent mechanisms are
stronger in the time period for the endpoint method
than in the kinetic method. However, overall, the
kinetic method is more negatively affected than the
endpoint method as can be seen from the scale of the
interference axis. In contrast to the multivariate ap-
proach we describe, each simple linear regression will
only yield one line of the surface response per exper-
iment. Evenjf many experiments were performed, one
would have to interpolate between lines which can be
marred by large errors if the non-linearities are large.
As one can see, this is not a problem with the muli-
variate approach.
Clinically, the derived polynomial equation allows one
to estimate the magnitude of the interference, as well
as to be able to solve for the true creatinine concen-
tration despite the conjugated bilirubin interference.
When equations for both unconjugated (11) and con-
jugated bilirubin are evaluated simultaneously, a bet-
ter estimation of the patient may result. However, at
this time, the effect of delta bilirubin remains un-
known.
Although the derived models are correlative, the terms
from the multiple regression suggest overall mecha-
nisms that are based on the general mechanisms of
interference (8). The analyte-independent term, the
freestanding bilirubin term, B, can represent many
possibilities. Classically, a spectral interference comes
to mind, but if that is case it is not constant as kinetic
method is affected to a greater degree. Bilirubin can
react reversibly or irreversibly with the reagents caus-
ing greater interference during the time of the kinetic
measurements. For example, bilirubin directly or in-
directly may tie up any of the enzymes. For example,
bilirubin may inhibit creatinine's reaction with crea-
tininase or any of the subsequent reactants with the
succeeding enzymes by temporarily binding to the
enzymes. It may be oxidized by oxygen which is a
reagent in the third step, thus slowing the oxidation
of sarcosine until the bilirubin is consumed. Any of
the Trinder reagents may also react either permanently
or reversibly with bilirubin and would be considered
analyte-independent mechanisms. The bilirubin2 term
in the six parameter endpoint model may suggest the
rare possibility of autoreaction, whereby bilirubin re-
acts with itself before partaking in the other discussed
mechanisms.
The analyte-dependent or cras -product terms, cre-
atinine χ bilirubin, creatinine2 χ bilirubin etc., imply
a reaction either with the analyte directly or a product
of the analyte and reagents. These can be side reac-
tions to the ususal coupled reaction in the phenol-
aminophenazone peroxidase method. A long-lived in-
termediate product formed among the interferent, the
substrate, and the enzyme. For example, bilirubin can
form a complex with one to two creatinine molecules
and creatinase. Such a model would also account for
the creatinine2 χ bilirubin term and higher terms.
Alternatively, bilirubin could react with more than
one enzyme complex or the various intermediate prod-
ucts. Not all reactions need cause a negative interfer-
ence but the sum of all the contributions will be
negative. One has to consider the possible reaction of
bilirubin with intermediate products such as sarcosine
or more likely, hydrogen peroxide. A short-lived in-
termediate is one mechanism that would account for
the greater interference in the kinetic mode (fig. 2).
At higher concentrations of creatinine, both the re-
duction of the interference in the endpoint mode and
the flat interference in the kinetic mode may be caused
by the analyte or its product intermediates, overtaking
the interferent's effect. It is possible that side reactions
of bilirubin with the other reactants would contribute
to the cross-product terms in the multiple regression
equations. Bilirubin interferes with several peroxi-
dase-coupled assays (19 — 22) which include choles-
terol, uric acid and triglycerides. Bilirubin may com-
pete with the Trinder reagent for hydrogen peroxide.
If this is the case, then it is the point where bilirubin
interferes with all these assays and interferences sim-
ilar to what we describe for the creatinine phenol-
aminophenazone peroxidase method can be expected.
Wine proposed that bilirubin destroys the interme-
diate or forms a long-life intermediate of the peroxi-
dase reaction (22).
Complex analyte-dependent/independent interfer-
ences have terms that are non-linear, meaning terms
with a power different from one. The non-linear term
implies either positive or negative feedback or coop-
eration. Positive feedback means that a chemical
which is either native to the reaction or exogenous to
it will enhance the reaction. Examples include free
radical reactions, enhanced binding at a second bind-
ing site after the first site is occupied such as oxygen
to haemoglobin, and of course, enzymatic reactions.
Autocatalytic reactions are a subclass of positive feed-
back. Negative feedback will produce a decreased
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reaction rate. Alternatively, the multiple regression
equation represents the first few terms in a two-
variable Taylor's series for a yet to be determined
non-linear function that describes the relationship
over the entire range and provides the mathematical
basis for a mechanism. We are exploring methods to
fit equations of the surface responses produced by the
experiment to produce a less cumbersome mathemat-
ical expression. The current analyses are similar to
thermodynamic studies in that we studied only the
endpoints of each reaction mode. Analysis of the
kinetic rate constants for each set of reactions can be
used to isolate the points of interference as well as to
define the true mechanisms (23).
In conclusion, we have demonstrated that bilirubin
not only interferes negatively with the creatinine phe-
nol-aminophenazone peroxidase methodology but it
does so in an analyte-independent and an analyte-
dependent manner. Furthermore, in the kinetic
method, the analyte-dependence is second-order non-
linear relationship with respect to creatinine, third-
order overall. The interference in the endpoint method
can be described by two possible models. One is a
fourth-order analyte-dependent model and the other
is a complex combined analyte-independent, analyte-
dependent model in which the highest terms are sec-
ond order with respect to creatinine and to bilirubin.
We may be the first to demonstrate such complex
non-linear terms that may denote positive and nega-
tive feedback reactions as underlying mechanisms of
interference. The two modes of measurement allowed
us to study an interfering reaction which changes with
time. The analyte-dependent component terms are
similar to that seen with unconjugated bilirubin (11).
The routine analysis of interferences, that is, simple
regression, failed to yield an adequate analysis. Con-
jugated bilirubin affected the kinetic method more
than the endpoint method. We also present evidence
that conjugated bilirubin interferes the kinetic method
more than unconjugated bilirubin for creatinine con-
centrations less than 1300 μηιοΐ/ΐ but converge to a
slope of —1.2 μηιοί creatinine per μπιοί bilirubin.
Unconjugated and conjugated bilirubin present simi-
lar interferences in the endpoint method at concen-
trations of creatinine below 1300 μιηοΐ/ΐ. Above this,
the interference decreases more rapidly for the uncon-
jugated bilirubin.
With the advent of desktop computers, multiple re-
gression analysis is a facile operation and can provide
a more accurate estimation of the relationship in-
volved. Simple linear regression is an inadequate tool
to study interferences because it shows only one line
of a surface response which is deceiving when there
is an analyte-dependent mechanism involved. This
approach should advance the analysis of interferences
and allow clinical chemists and chemical pathologists
to make sense out of comparisons with other studies
that may produce different slopes because of the dif-
ferent range studied, and yet accurately describe the
relationship over a small interval. It would be desir-
able for instrument manufacturer's to provide similar
analyses on interferences.
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